Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

3D-Printed Microneedles Advance Toward Closed-Loop Theranostic Platforms

A review traces how 3D-printed microneedles are evolving from passive drug delivery tools into integrated theranostic platforms, while noting translation barriers.

By Dr. Revathy Mohan V.R., MBBS · Nov 5, 2026 · 5 min read

Oncology·Cancer Cell

MRPL47 Ovarian Cancer Biomarker Study Lacks Full Abstract Text

Only the article title was provided, so no accurate clinical rewrite can be produced without inventing study methods,…

Nov 5, 2026

Oncology·Cancer Cell

Morpholino NELFE splice switching shows preclinical activity in hepatocellular carcinoma

Preclinical work in hepatocellular carcinoma found that morpholino-mediated splice switching of NELFE suppressed tumor cell phenotypes in vitro…

Nov 5, 2026

Oncology·Cancer Cell

Cell death research moves from mechanism to intervention

Researchers reviewing programmed cell death describe how emerging mechanisms are reshaping immunity, development, and therapeutic intervention strategies.

Nov 5, 2026

Oncology·Cancer Cell

Endometrial Cancer Microbiome Alters Risk, Progression and Immunotherapy Response

A cross-compartment review links gut, cervicovaginal, uterine and intratumoral microbiome shifts to endometrial cancer biology and pembrolizumab response.

Nov 5, 2026

Oncology·Cancer Cell

Glioma progression linked to non-synaptic neural microenvironment interactions

A Frontiers in Oncology review traces how non-synaptic neural microenvironment signaling shapes glioma invasion, symptoms, and treatment resistance.

Nov 5, 2026

Oncology·MHRA

NHS blood test trial targets earlier detection of abdominal cancers

England will launch a 20,000-patient NHS trial of blood tests for earlier detection of abdominal cancers across more…

Nov 5, 2026

Oncology·Nature

UBE2T Drives Metastatic Breast Cancer Chemoresistance, BET Inhibitors Reverse It

Preclinical breast cancer research links the NFYA/UBE2T/p-AKT axis to metastatic chemoresistance and shows BET inhibitors can restore drug…

Nov 5, 2026

Oncology·Cancer Disc

HERV-K Envelope Expression in Lymphoma Points to New Treatment Target

A Cancer Discovery abstract describes aberrant HERV-K envelope expression in lymphoma, raising the possibility of a new tumor-targeted…

Nov 5, 2026

Oncology·Sci Transl Med

TIMP-1 Nanoparticles Replicate Anti-Angiogenic Signaling in Ewing Sarcoma

Bioinspired TIMP-1 nanoparticles suppressed endothelial sprouting and tumor vessel infiltration in Ewing sarcoma models, unlike soluble TIMP-1.

Nov 5, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.